<DOC>
	<DOCNO>NCT02693587</DOCNO>
	<brief_summary>In Denmark , every 4 birth induce , often due prolonged pregnancy , til 10-12 day term . A group ( RADS ) set Danish Regions recently recommend induction prostaglandin tablet form ( Angusta® ) . The recommendation base primarily result meta-analysis publish Cochrane Library , various prostaglandin medication compare . Vaginal prostaglandin insert ( Misodel® ) prove safe American Studies register Denmark use induction . Misodel® include RADS 's evaluation , study effectiveness side effect . In current study , investigator want compare two different regime induction primipara use respectively Misodel® Angusta® primary method . The study base prospective collection data three division Region Zealand , investigator primarily compare efficacy safety also evaluate woman 's experience , cost medicine consumption resource maternity ward .</brief_summary>
	<brief_title>Misodel Angusta Induction Labour ?</brief_title>
	<detailed_description>Background The incidence induce labour Denmark , increase 12 % year 2000 25 % , 2014 . This increase primarily due policy earlier induction woman prolong pregnancy expect decrease risk intrauterine fetal death . The national guideline change 2012 . Aim study To compare regimen use 25 mcg peroral misoprostol ( Angusta® ) 200 mcg vaginal insert Misoprostol ( Misodel® ) population nullipara unripened cervix . The regimen compare term technology ( efficacy safety ) , organisation , economy patient-satisfaction . Patients : In region Zeeland , 6360 birth annually , among 1636 ( 25 % ) birth induce . Among primipara 493 ( 29 % ) induction 2013 . The number cover induced birth , i.e . medically , balloon-catheter , amniotomy . In Holbæk Hospital ( 2013 ) , 373 woman induce among 190 primipara . In Næstved Hospital number induction 393 177 primipara . Regimes induction : There exist number different regime induction labour . When cervix unripened , general consensus induction either prostaglandin balloon catheter . A committee appoint Danish Regions ( RADS ) launch 2014 recommendation use prostaglandins induction labour . The recommendation summarize Table 1 . The recommendation conclude Angusta® first line treatment induction labour prostaglandin . Table 1 : Prostaglandins induction labour Prostaglandin Trade name Approved Ministry health RADS recommendation Misoprostol tablet , 25 mcg Angusta® Not approve Recommended : ( 2 h x 8 ) Dinoproston vaginal tablet gel 3 mg Prostin® Minprostin® Approved Can use : ( 6 h x 3 ) Misoprostol vaginal tablet 25 mcg Approved Can use : ( 4 h x 4 ) Misoprostol tablet , 50 mcg Approved Can use : ( 4 h x 4 ) Misoprostol insert 200 mcg Misodel® Approved Not recommend Dinoproston insert 10 mg Propess® Approved Not recommend The quality evidence strength recommendation base evaluation method GRADE ( Grading recommendation Assessment , Development Evaluation ) . The conclusion primary base Cochrane analysis June 2014 . Conclusions analysis : - Oral Misoprostol effective placebo , lead low risk caesarean delivery dinoproston . - Oral Misoprostol equally effective administer vaginally , increase risk low Apgar score post-partum bleeding . Recently , conclusion Cochrane analysis debate . It argue evidence effectiveness/equivalence base study oral misoprostol use high dosage ( &gt; 25 mcg ) , whereas study conclude increase risk complication , use small dosage . Misodel® : Misoprostol insert 200 mcg ( Misodel® ) register Europe induction labour . The effect safety document study US . One randomize control study publish 2008 , compare vaginal insert 50 100 mcg misoprostol vaginal insert 10 mg Dinoproston . The two primary outcome duration administration delivery , frequency caesarean section ( CS ) . It find 100 mcg misoprostol 10 mg dinoprostone duration start induction delivery , whereas 50 mcg misoprostol show prolonged duration . The frequency CS . In 2011 , result another RCT publish , compare vaginal misoprostol insert 100 , 150 200 mcg . It find 200 mcg group deliver within 25,8 hour nulliparous , 14 hour multiparous woman . The rate CS increase group , due affect fetal heart-rate , although significant . There differences neonatal outcome . Tachysystoli ( hyper-stimulation ) frequent , few need stimulate oxytocin ( 49 % ) . One RCT 2013 compare 200 mcg slow release misoprostol 10 mg Dinoproston insert . Their result show short duration delivery ( 21,5 vs 32,8 hour ) , frequency CS . RADS include Misodel® analysis since find RCTs investigated effect vs. side-effect Misodel® compare regime . The background recommending , seem high risk tachysystoli CTG change - although base different dosage . The current trial : This study design compare 2 different regimen induction labour nullipara unripened cervix use medical health technology assessment . Patients : Inclusion criterion : Primipara , immature cervix ( Bishop score &lt; 4 ) , gestational age &gt; 37+0 week singleton pregnancy without suspicion fetal growth retardation ( SGA define birth-weight deviation ≤−22 % ) , history prelabor rupture membrane ( PROM ) . No GDM . Exclusion criterion : GA &lt; 37+0 week , multipara , multiple pregnancy , placenta previa , suspicion SGA , PROM , GDM . Methods The obstetric department Region Zeeland , elaborate clinical guideline Angusta® expect fully implement Hospitals Roskilde , Næstved Nykøbing Falster June 2015 . The guideline base recommendation RADS . The department Obstetrics Holbæk develop another guideline Misodel® use first line treatment select population . The woman give birth Roskilde , Næstved Holbæk comparable number parameter ( BMI , distance hospital , smoking , frequency CS , cup-delivery etc. ) . This data already available . The project base prospective collection data induce labour Roskilde , Næstved Holbæk . Investigators also collect correspond data spontaneous delivery term three different department . Primary outcome : - Frequency caesarean section . - Frequency hyperstimulation , define tachysystoly &gt; 5 contraction 10 minute period 30 minute . Indeterminate abnormal CTG . Scalp-pH &lt; 7,20 umbilical cord pH &lt; 7,10 . - Frequency delivery within 24 hour induction . Secondary outcome : - Time induction delivery - Daytime delivery ( 8am-7pm ) - Number hour Syntocinon stimulation - Use ballon-catheter - Epidural - Numbers duration contact labour ward - Number vaginal exploration active labour - Duration CTG monitoring - Fever - Expenses medication per induction ( prostaglandin , syntocinon , balloon-catheter ) - Patient experience ( evaluate base questionnaire ) - Midwife experience ( evaluate base questionnaire ) - Breastfeeding ( questionnaire 3 month delivery ) Statistical analysis : Outcome compare two department calculation Odds Ratio ( OR ) , 95 % confidence interval ( CI ) . There adjusted confounders BMI , maternity age , birth weight , gestational age , indication induction logistical regression analysis . Datasource : Approval data protection authority apply . Besides questionnaire , information available electronic patient-charts , include MILOU ( program store CTG electronically ) . Material size strength-calculations primary outcome : Material size determine Kelsey method significance level 5 % power 80 % . For effective trial , would like set ratio 2:1 control : Misodel® group . - Caesarean section : A difference 2 % estimate relevant ( expect difference 20 22 % ) . We need include 4150 induced birth Misodel® group 8300 patient control group . - Hyperstimulation : difference frequency tachysystoli 15 % estimate relevant ( 40 55 % ) . We need include 126 252 patient Misodel® control group . - Birth within 24 hour : A difference 15 % estimate relevant , result ( 40 55 % ) : 126 252 patient per group . - We plan include 140 induced woman Misodel® group , 280 control group . After inclusion 70 woman , investigator perform interims-analysis . The investigator expect see significant difference CS . Timeline : The guideline induction Misodel® implement Holbæk November 2015 . The prospective collection data expect commenced November 2015 , finish number patient need reach ( accord sample size-calculations ) , presumably 1-2 year . Questionnaires patient satisfactory elaborate validate May 2015. Financing conflict interest : There additional cost medication staff hospital Holbæk . Funding study apply private public fund , none pay pharmaceutical company . Lone Krebs , Morten Lebech Lisbeth Jønsson declare conflict interest . Data : Data collect stored Axelina Eriksson ( AE ) Holbæk Sygehus , department Gynaecology Obstetrics , lock office intern department . Questionnaires locked drawer AE key . Personal electronical data access AE alone office , collection information store AEs ' personal login teamsite . A backup USB key store locked drawer , questionnaire . When data process office , anonymized , leave office anonymization . The project schedule finish 1/12-17 - personal sensitive data destroy afterwards .</detailed_description>
	<criteria>Primipara , immature cervix ( Bishop score &lt; 4 ) , gestational age &gt; 37+0 week singleton pregnancy without suspicion fetal growth retardation ( SGA define birthweight deviation ≤−22 % ) , history prelabor rupture membrane ( PROM ) . No GDM . GA &lt; 37+0 week , multipara , multiple pregnancy , placenta previa , suspicion SGA , PROM , GDM .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>